BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18566232)

  • 1. DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis.
    Wallach-Dayan SB; Rubinstein AM; Hand C; Breuer R; Naor D
    Mol Cancer Ther; 2008 Jun; 7(6):1615-23. PubMed ID: 18566232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function.
    Yu Q; Toole BP; Stamenkovic I
    J Exp Med; 1997 Dec; 186(12):1985-96. PubMed ID: 9396767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 variant DNA vaccination with virtual lymph node ameliorates experimental autoimmune encephalomyelitis through the induction of apoptosis.
    Garin T; Rubinstein A; Grigoriadis N; Nedvetzki S; Abramsky O; Mizrachi-Koll R; Hand C; Naor D; Karussis D
    J Neurol Sci; 2007 Jul; 258(1-2):17-26. PubMed ID: 17382349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma.
    Witt K; Ligtenberg MA; Conti L; Lanzardo S; Ruiu R; Wallmann T; Tufvesson-Stiller H; Chambers BJ; Rolny C; Lladser A; Lundqvist A; Cavallo F; Kiessling R
    Cancer Immunol Res; 2018 Nov; 6(11):1417-1425. PubMed ID: 30143536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes.
    Wallach-Dayan SB; Grabovsky V; Moll J; Sleeman J; Herrlich P; Alon R; Naor D
    J Cell Sci; 2001 Oct; 114(Pt 19):3463-77. PubMed ID: 11682606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
    Harada N; Mizoi T; Kinouchi M; Hoshi K; Ishii S; Shiiba K; Sasaki I; Matsuno S
    Int J Cancer; 2001 Jan; 91(1):67-75. PubMed ID: 11149422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccination against neu reduces breast cancer incidence and metastasis in mice.
    Lachman LB; Rao XM; Kremer RH; Ozpolat B; Kiriakova G; Price JE
    Cancer Gene Ther; 2001 Apr; 8(4):259-68. PubMed ID: 11393278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
    Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
    Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers.
    Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J
    Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
    Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
    Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
    Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
    Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma.
    Cavallo F; Di Pierro F; Giovarelli M; Gulino A; Vacca A; Stoppacciaro A; Forni M; Modesti A; Forni G
    Cancer Res; 1993 Nov; 53(21):5067-70. PubMed ID: 8221636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
    Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
    Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
    Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor.
    Guiducci C; Di Carlo E; Parenza M; Hitt M; Giovarelli M; Musiani P; Colombo MP
    J Immunol; 2004 Apr; 172(7):4026-36. PubMed ID: 15034014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model.
    Shibata MA; Morimoto J; Shibata E; Otsuki Y
    Cancer Gene Ther; 2008 Dec; 15(12):776-86. PubMed ID: 18654613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.
    Yu Q; Stamenkovic I
    Genes Dev; 1999 Jan; 13(1):35-48. PubMed ID: 9887098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expressions of CD44 variants in tumors affecting the central nervous system.
    Resnick DK; Resnick NM; Welch WC; Cooper DL
    Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.